Evaluation of Prototype Solutions for Optimizing Maternal Health Behaviors
1 other identifier
interventional
1,024
1 country
1
Brief Summary
This study is a three-year implementation research project that aims to develop and test the effectiveness and acceptability of interventions to promote three outcomes: institutional delivery, antenatal care, and iron-folic acid supplementation among pregnant women in Ethiopia. The project applies a Human-Centered-Design (HCD) to develop prototype solutions that optimize the uptake and adherence to maternal and child health services by pregnant women. The evaluation of high-fidelity prototype solutions that come out from a sprint workshop (rapid HCD) and an extended HCD process will take place across two phases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 8, 2023
CompletedFirst Posted
Study publicly available on registry
June 18, 2023
CompletedStudy Start
First participant enrolled
July 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 24, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
ExpectedNovember 18, 2025
November 1, 2025
2.3 years
June 8, 2023
November 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in institutional delivery rates assessed by the survey instrument
Institutional delivery will be measured using a question that asks about a place of child birth in most recent pregnancy
Baseline and 4 months
Change in the number of antenatal care visits assessed by the survey instrument
The outcome will be measured using a question that asks about the number of antenatal care visits women had during current pregnancy.
Baseline and 4 months
Study Arms (2)
Intervention Arm
EXPERIMENTALThe intervention arm will receive a package of behavioral interventions in addition to usual care in health facilities.
Control Arm
NO INTERVENTIONThe control arm will not receive any intervention other than usual care.
Interventions
The intervention package will include various social and behavior change programs derived from a human-centered design approach. The intervention will be tailored to vulnerable pregnant women's needs and contexts. It may include but is not limited to health communication campaigns, including radio and print media.
Eligibility Criteria
You may qualify if:
- Pregnant 5+ months
- to 49 years
- moderate to high vulnerability
You may not qualify if:
- Pregnant less than 5 months
- non-reproductive age
- low vulnerability
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Center for Communication Programs
Addis Ababa, Ethiopia
Study Officials
- PRINCIPAL INVESTIGATOR
Rajiv Rimal, PhD
Johns Hopkins Bloomberg School of Public Health
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 8, 2023
First Posted
June 18, 2023
Study Start
July 18, 2023
Primary Completion
October 24, 2025
Study Completion (Estimated)
June 30, 2026
Last Updated
November 18, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Proposals may be submitted up to 36 months following article publication. After 36 months the data will be available in our University's data warehouse but without investigator support other than deposited metadata.
Individual participant data that underlie the results reported in a publication will be shared after deidentification. The data will be shared with researchers whose proposed use of the data has been approved by an independent review committee for individual participant data meta-analysis.